Author: user

Wednesday, an analyst from KeyBanc increased the stock price target for The Trade Desk (NASDAQ:) shares to $130 from the previous $115 while keeping an Overweight rating on the stock. The analyst expects the company’s revenue to at least meet the projected $623 million, which is slightly above the consensus estimate of $620 million. Moreover, there is a belief that the fourth-quarter guidance might surpass both the analyst’s and the Street’s forecasts of $753 million and $750 million, respectively. The Trade Desk, a prominent player in the advertising technology sector, is anticipated to experience a growth in revenue of over…

Read More

Listen and subscribe to Opening Bid on Apple Podcasts, Spotify, YouTube or wherever you find your favorite podcasts.Some shine is due to come off the red-hot gold trade.“Gold is fascinating, and I think people are certainly starting to hedge their bets,” Kathryn Rooney Vera, chief markets strategist at StoneX, told Yahoo Finance Executive Editor Brian Sozzi on the Opening Bid podcast (video above; listen below). Gold is beginning to look “long in the tooth,” said Rooney Vera, adding, “I would also realize gains anticipating some correction therein.”This embedded content is not available in your region.Gold (GC=F) has been one of…

Read More

Image source: Getty Images Today (9 October), UK small-cap stock Netcall (LSE: NET) delivered a pleasing full-year results report. I’d give it some serious consideration as a potential buy if I wasn’t already fully invested without any spare cash. An attractive sector The business operates as a provider of intelligent automation and customer engagement software. That’s promising because software is a sub-sector of the market that has produced some multi-bagging growth businesses over the past few years. However, smaller companies do come with elevated risks. This one has a market capitalisation of just £141m and it lives in the FTSE…

Read More

On Wednesday, Citi maintained a Buy rating on Cummins (NYSE:CMI) and increased the price target to $375 from $345. The revision reflects updated earnings per share (EPS) estimates for the upcoming years, as detailed by the firm’s latest model changes. The firm has adjusted its 2024 EPS estimate for Cummins upward to $19.65, a slight increase from the previous $19.55 forecast. This adjustment is attributed to more optimistic projections for the North American On-Highway market, which is expected to perform better than initially thought. Conversely, the 2025 EPS estimate has been revised downward to $21.65 from $21.75. This decrease is…

Read More

US stock futures stalled on Wednesday as the risk of a Google breakup prompted a pause for thought in the wait for more Federal Reserve clues to the chances of a “soft landing.”Futures on the Dow Jones Industrial Average (YM=F), the S&P 500 (ES=F), and the tech-heavy Nasdaq 100 (NQ=F) all hovered below the flat line, paring earlier premarket losses.Stocks have whipsawed this week amid intense debate over the state of the economy now the Fed has finally eased up on policy. Its decision to cut by a jumbo 50 basis points raised concerns it might see risks the market…

Read More

The Honda CB550F, a classic motorcycle from 1976, has been transformed into a stunning cafe racer by Basti Happ of 089moto. Despite its low mileage, the bike was in a neglected state when Basti acquired it. However, he saw its potential and started on a meticulous customization project. The result is a breathtaking cafe racer that blends modern aesthetics with classic charm. Basti’s transformation of the CB550F involved a complete overhaul of the bike’s appearance and performance. He fabricated a new loop style subframe, replaced the stock seat with a bespoke leather saddle, and added a sleek cafe racer tail…

Read More

Image source: Getty Images I’ve been watching the Greggs (LSE: GRG) share price for months, wondering whether this was a good time to buy it. Britain’s favourite bakery chain has turned itself into a national treasure, supplying traditional fayre like sausage rolls and steak bakes, without feeling stodgy or old-fashioned itself. Unlike so many retailers, the cost-of-living crisis did it a favour, as cash-strapped shoppers saw a trip to Greggs as an affordable treat. Greggs has been marketed brilliantly, from its clothing range (with Primark) to its legendary vegan sausage rolls. I’m not sure how many it actually sold, but…

Read More

FRIENDSWOOD, Texas–(BUSINESS WIRE)–Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will present new data related to its DecisionDx-Melanoma and DecisionDx ®-UM tests for patients with cutaneous melanoma (CM) and uveal melanoma (UM), respectively, at the 21st International Congress of the Society for Melanoma Research (SMR), taking place Oct. 10-13, 2024, in New Orleans. In large prospective and retrospective studies, our DecisionDx-Melanoma test has been shown to provide clinical value above and beyond current staging paradigms and other tests currently available for patients with cutaneous melanoma, said Derek Maetzold,…

Read More

Image source: Rolls-Royce plc Rolls-Royce’s (LSE: RR) share price is now trading near a 12-month high, following a dip at the beginning of September to £4.56. This came after the in-flight failure on 30 August of a part in a Cathay Pacific A350-1000 Rolls-Royce XWB-97 engine. However, the European Union Aviation Safety Agency (EASA) said on 19 September that the failure may not have been a structural flaw in the engine nozzle. It may instead have been due to a process used to clean the fuel hose. How do the growth prospects look? The day before the EASA statement, Rolls-Royce…

Read More

Investing.com — Shares in WeightWatchers surged by nearly 38% in extended hours trading on Wednesday, pointing to an extension in sharp gians logged in the prior session after the firm announced it would offer a compounded version of Novo Nordisk (NYSE:)’s popular weight-loss drug Wegovy. Major drug companies, including Denmark’s Novo Nordisk and peer Eli Lilly (NYSE:), have struggled to keep up with the soaring demand for their blockbuster GLP-1 obesity medications, which have been shown to help patients lose up to 20% of their weight on average. Because of this shortage, US regulators have allowed businesses, including telehealth groups like…

Read More